StonvexLoading…
StonvexStonvexStonvexCore line items from HSY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $11.69B | $11.20B | $11.16B | $10.42B |
Operating Income | $1.44B | $2.90B | $2.56B | $2.26B |
Net Income | $883.26M | $2.22B | $1.86B | $1.64B |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $13.74B | $12.95B | $11.90B | $10.95B |
Total Liabilities | $9.10B | $8.23B | $7.80B | $7.65B |
Cash & Equivalents | $925.86M | $730.75M | $401.90M | $463.89M |
Free Cash Flow OCF − CapEx | $1.82B | $1.93B | $1.55B | $1.81B |
Shares Outstanding | 202.84M | 202.38M | 204.39M | 204.96M |